leaning towards the negative side. 2 is my vote.
it's all about risk/reward. if death rates are equal as other non-approved drugs, then i dont know if it's increase effectiveness is enough to overcome the safety concern.
it's as safe as anything out there, but the problem is that everything out there is not approved. so using the same logic, this should not be approved.